WO2021064594A1 - Contenant de produit pharmaceutique - Google Patents

Contenant de produit pharmaceutique Download PDF

Info

Publication number
WO2021064594A1
WO2021064594A1 PCT/IB2020/059151 IB2020059151W WO2021064594A1 WO 2021064594 A1 WO2021064594 A1 WO 2021064594A1 IB 2020059151 W IB2020059151 W IB 2020059151W WO 2021064594 A1 WO2021064594 A1 WO 2021064594A1
Authority
WO
WIPO (PCT)
Prior art keywords
bottle
container
support
compartment
tab
Prior art date
Application number
PCT/IB2020/059151
Other languages
English (en)
Inventor
Corrado DIAZ GONZALES OLIVETTI
Original Assignee
Eurpack Giustini Sacchetti S.R.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurpack Giustini Sacchetti S.R.L. filed Critical Eurpack Giustini Sacchetti S.R.L.
Priority to EP20796645.8A priority Critical patent/EP4037982B1/fr
Publication of WO2021064594A1 publication Critical patent/WO2021064594A1/fr

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D5/00Rigid or semi-rigid containers of polygonal cross-section, e.g. boxes, cartons or trays, formed by folding or erecting one or more blanks made of paper
    • B65D5/42Details of containers or of foldable or erectable container blanks
    • B65D5/44Integral, inserted or attached portions forming internal or external fittings
    • B65D5/50Internal supporting or protecting elements for contents
    • B65D5/5028Elements formed separately from the container body
    • B65D5/5035Paper elements
    • B65D5/504Racks having upstanding ridges formed by folds, and provided with slits or recesses
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D5/00Rigid or semi-rigid containers of polygonal cross-section, e.g. boxes, cartons or trays, formed by folding or erecting one or more blanks made of paper
    • B65D5/42Details of containers or of foldable or erectable container blanks
    • B65D5/54Lines of weakness to facilitate opening of container or dividing it into separate parts by cutting or tearing
    • B65D5/545Lines of weakness to facilitate opening of container or dividing it into separate parts by cutting or tearing for opening containers formed by erecting a "cross-like" blank
    • B65D5/5455Lines of weakness to facilitate opening of container or dividing it into separate parts by cutting or tearing for opening containers formed by erecting a "cross-like" blank the lines of weakness being provided in a closure hinged to an edge of the container body

Definitions

  • This invention relates to a pharmaceutical product container of the type described in the preamble to the first claim.
  • this invention relates to partitioning means designed to create compartments or sections intended to contain bottles containing pharmaceutical products in the liquid state.
  • pharmaceutical product packagings basically comprise at least one primary and one secondary container.
  • the primary container is preferably designed to directly contain the pharmaceutical product, whether solid or liquid, and can therefore consist of a peel-off sheet defining a plurality of capsules, such as common blisters, or a vial, for example for containing liquid substances.
  • Secondary containers are designed to contain one or more primary containers.
  • secondary containers basically define a box shape that can be easily opened and closed and that is usually in the shape of a rectangular parallelepiped and made of material such as paper.
  • These secondary containers therefore define foldable faces including tabs configured to be interlocked inside specific slots or rested on another face, so as to create the secondary container.
  • the secondary container may include partitioning means.
  • the partitioning means are cardboard walls designed to define separate compartments.
  • partitioning means may also be provided the walls of which are basically counter-shaped to the bottles themselves.
  • the prior art described here has some significant drawbacks.
  • the partitioning means only enable separate compartments to be created, but do not provide any indication regarding the use of the bottles.
  • the bottle could be easily removed, used, and returned to the compartment, without any kind of warning.
  • the containers of the prior art do not sufficiently comply with the new anti-tampering standards and, for this reason, they are now hardly usable and not suitable for correctly containing the pharmaceutical product inside.
  • the technical task underlying this invention is to devise a pharmaceutical product container that is capable of basically overcoming at least some of the above-mentioned drawbacks.
  • one important purpose of the invention is to obtain a pharmaceutical product container that is capable of providing indications regarding the use of the bottles of the pharmaceutical product.
  • Another important purpose of the invention is to create a container that meets the new anti-tampering standards and that is not easily opened without its being possible to detect tampering.
  • Fig. 1 shows a perspective view of the partition of a pharmaceutical product container according to the invention in which there are two compartments for two bottles of a pharmaceutical product;
  • Fig. 2 illustrates a side view of the partition of a pharmaceutical product container according to the invention in which there is one bottle;
  • Fig. 3 is a pre-assembly template for the partition of a pharmaceutical product container according to the invention.
  • Fig. 4 represents a pre-assembly template for the casing of a pharmaceutical product container according to the invention.
  • the measures, values, shapes and geometric references (such as perpendicularity and parallelism), when used with words like “about” or other similar terms such as “approximately” or “substantially”, are to be understood as except for measurement errors or inaccuracies due to production and/or manufacturing errors and, above all, except for a slight divergence from the value, measure, shape or geometric reference with which it is associated. For example, if associated with a value, such terms preferably indicate a divergence of no more than 10% from the value itself.
  • the measurements and data reported in this text shall be considered as performed in International Standard Atmosphere ICAO (ISO 2533:1975).
  • the number 1 globally denotes the pharmaceutical product container according to the invention.
  • the container 1 is preferably configured to include a pharmaceutical product contained in bottles. Therefore, the pharmaceutical product is preferably liquid. However, the pharmaceutical product could equally be in the form of solid or semi solid tablets and still be included inside bottles 10.
  • the bottles 10 are, as is well known, basically bottle-shaped casings that mainly have a closed cylindrical body that narrows towards the outlet of the bottle.
  • the outlet is made from the neck of the bottle 10 and, generally, also includes a closing cap to isolate the internal volume of the bottle 10 from the outside.
  • the container 1 therefore, comprises at least one partition 2.
  • the partition 2 has, for the most part, the purpose of compartmentalising at least part of the container 1 and of supporting at least one bottle 10 in a stable manner.
  • the partition 2 is preferably also designed to separate a plurality of bottles 10.
  • the container 1 thus, essentially comprises at least one bottle 10, but preferably comprises a plurality of bottles 10, for example two.
  • the partition 2 is configured to create at least one compartment 20.
  • the compartment 20 is preferably designed to include a bottle 10 of pharmaceutical product.
  • the compartment 20 is, therefore, a space or a cavity present in the partition 2 and is designed to enable the insertion of the bottle 10, as shown, for example in Fig. 1 .
  • the partition 2 comprises, in addition, at least one first support 21 and one second support 22.
  • the first support 21 and the second support 22 basically create, at least partially, at least one compartment 20. They may, however, also partially define a plurality of compartments 20. Basically, then, the first support 21 and the second support 22 are edges designed to include the bottle 10 resting on its ends.
  • the bottle 10 in fact, comprises at least two ends. A first end, which can be the neck of the bottle 10, and a second end, which can be the resting base of the bottle 10.
  • the first support 21 is preferably designed to support at least the first end of a bottle 10.
  • the second support 22 is, on the other hand, preferably designed to support at least the second end of the bottle 10.
  • At least one of the supports 21 , 22 includes locking means 3.
  • the locking means 3 are configured to lock at least one end of the bottle 10.
  • the locking means 3 are configured to define at least one rip when the bottle 10 is removed from the compartment 20. Basically, therefore, the removal of the bottle 10 from the compartment 20 entails the rupture of at least part of the locking means 3, created by the rip, so as to immediately make it clear that the container 1 has been tampered with.
  • stampering refers, mainly, to the first use following the packaging of the container 1 .
  • the locking means 3 are comprised in the first support 21 . In any case, they could also be comprised, at the same time or alternatively, in the second support 22.
  • both the first support 21 , and any second support 22, may include a plurality of locking means 3.
  • they may include locking means 3 for each compartment 20 defined by the supports 21 , 22.
  • the locking means 3 comprise a tab 30.
  • the tab 30 is, preferably, an almost flat portion protruding from one of the supports
  • the tab 30 is, therefore, preferably attached to one of the supports 21 , 22.
  • the tab 30 is attached to one of them at at least two attachment areas 31.
  • the attachment areas 31 are preferably the hooking portions between tab 30 and support 21 or 22. They may consist, for example, of simple folds designed to enable the tab 30 to rotate in relation to the support 21 or 22.
  • the attachment areas 31 are separate and spaced apart. Basically, therefore, the tab 30 is connected to one of the supports 21 , 22 at at least two distinct and separate points.
  • the tab 30 is designed to resist the removal of one of the ends of the bottle 10 from the compartment 20. In this way, when the bottle 20 is removed from the compartment 20, the tab 30 defines the rip (described above) in relation to the support 21 , 22 at at least one attachment area 31 .
  • the attachment at two separate attachment areas 31 prevents the movement of the tab 30 in relation to the support 21 or 22 and any movement of the same tab 30 can, therefore, be carried out, as happens when the bottle 10 is removed, only by breaking at least one attachment area 31 .
  • the tab 30 is directly attached, therefore, at one primary end 30a, to one of the supports 21 , 22 so as to create one of the attachment areas 31 .
  • the tab 30 is additionally attached to the support 21 or 22 by means of the connection 32 so as to create the other attachment area 31 .
  • the latter attachment area 31 is defined at one secondary end 32a of the connection 32.
  • the rip is preferably made by the connection 32 when the bottle 10 is removed from the compartment 20.
  • the tab 30 and the connection 32 are attached together at, respectively, a third end 30b, opposite the primary end 30a, and a fourth end 32b, opposite the secondary end 32a.
  • the tab 30 and the connection 32 are attached, indicatively, at these ends 30b, 32b. They are not necessarily attached to the end, but also close to the ends, as clearly shown, for example, in Fig. 2.
  • the partition 2 preferably consists of a single piece beginning with a single, flat pre-assembly template.
  • the tab 30 and the connection 32 are attached together when the partition is assembled, for example via gluing.
  • the third end 30b is, preferably but not exclusively, configured to come into contact with one of the ends of the bottle 10 to lock the bottle 10 itself.
  • the locking means 3 can, in addition, comprise a locking base 33.
  • the locking base 33 can be a portion of the first or second support 21 , 23 designed to sustain, via gravity, one end of the bottle 10.
  • the locking base 33 is preferably designed to sustain the first end of the bottle 10, i.e. the neck.
  • the tab 30 is preferably opposite the resting base 33 so that, when the bottle 10 is arranged within the compartment 20, the first end of the bottle 10 is locked between the resting base 33 and the tab 30.
  • the third end 30b of the tab 30 is preferably counter-shaped to the first end of the bottle 10, i.e. to the neck.
  • the locking means 3 are preferably arranged near the first support 21 so as to lock the first end of the bottle 10.
  • the second support 22 comprises a second resting base 4.
  • the second resting base 4 is, preferably, designed to sustain, via gravity, the second end of the bottle 10.
  • the resting base 4 can, therefore, be a flat base or it can also be counter-shaped to the base, i.e. the second end, of the bottle 10.
  • the resting base 4 can, in addition, support the bottle 10 basically resting on the bottom of the partition 2 or of the container 1 , as shown in Fig. 2, or suspended above the bottom and spaced apart from it as happens, preferably, for the locking base 33.
  • the supports 21 , 22 preferably each create cavities
  • the cavities 23 preferably define part of the compartment 20.
  • they are at least partially counter-shaped to, respectively, the first end and to the second end of the bottle 10.
  • the container 1 described can also comprise, in addition, a casing 5.
  • the casing 5 is preferably a box-shaped element designed to create a closed volume isolated from the outside, but accessible, on command, by the user.
  • the casing 5 preferably houses the partition 2.
  • the casing 5 also includes at least one bottle 10, preferably a plurality of bottles 10 housed, in their turn, in the partition 2.
  • the casing 5 is, thus, basically known in the current state of the art and comprises a cover 50.
  • the cover 50 is, thus, designed to cover an opening of the casing 5, which enables access inside the casing 5.
  • the cover 50 is preferably delimited by notches 51.
  • the notches 51 are preferably designed to enable the cover 50 to be ripped open.
  • the cover 50 therefore, once open, also makes it possible to warn the user that the container 1 has been opened.
  • the pharmaceutical product container 1 according to the invention achieves important advantages.
  • the container 1 makes it possible to warn the user of any tampering with the contents thanks to the rips identified in the attachment areas 31 of the locking means 3.
  • the cover 50 also makes it possible to additionally warn the user whether the contents of the container 1 have been used or accessed.
  • an additional advantage of the container 1 is that of responding to the new anti-tampering standards, reducing, if not eliminating, the possibility of tampering with the pharmaceutical product contained in the container 1.

Landscapes

  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Details Of Rigid Or Semi-Rigid Containers (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

L'invention concerne un contenant (1) destiné à un produit pharmaceutique comprenant une séparation (2) conçue pour créer au moins un compartiment (20) destiné à une bouteille (10) du produit pharmaceutique et comprenant au moins un premier support (21) conçu pour soutenir au moins une première extrémité de la bouteille (10) et un second support (22) conçu pour soutenir au moins une seconde extrémité, opposée à la première extrémité, de la bouteille (10), au moins l'un des supports (21, 22) comprenant des moyens de blocage (3) conçus pour bloquer au moins une extrémité de la bouteille (10) et pour définir au moins un accroc lorsque la bouteille (10) est retirée du compartiment (20) afin de rendre apparent l'altération du contenant (1).
PCT/IB2020/059151 2019-10-03 2020-09-30 Contenant de produit pharmaceutique WO2021064594A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP20796645.8A EP4037982B1 (fr) 2019-10-03 2020-09-30 Contenant de produit pharmaceutique

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT102019000017912 2019-10-03
IT201900017912 2019-10-03

Publications (1)

Publication Number Publication Date
WO2021064594A1 true WO2021064594A1 (fr) 2021-04-08

Family

ID=69701255

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2020/059151 WO2021064594A1 (fr) 2019-10-03 2020-09-30 Contenant de produit pharmaceutique

Country Status (2)

Country Link
EP (1) EP4037982B1 (fr)
WO (1) WO2021064594A1 (fr)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1185582A (fr) * 1957-10-30 1959-08-03 Allard & Fils Plateau porte-bouteilles
EP0028995A1 (fr) * 1979-11-08 1981-05-20 COMPAGNIE FRANCAISE D'EMBALLAGES ET DE CONDITIONNEMENT - COFREC Société anonyme Emballage pour ampoules pharmaceutiques ou similaires
FR2734795A1 (fr) * 1995-05-31 1996-12-06 Packart Boite en carton, paquet la comprenant, procede et realisation du paquet et son installation, pour objets allonges
EP2050680A1 (fr) * 2007-10-16 2009-04-22 Dividella AG Emballage

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1185582A (fr) * 1957-10-30 1959-08-03 Allard & Fils Plateau porte-bouteilles
EP0028995A1 (fr) * 1979-11-08 1981-05-20 COMPAGNIE FRANCAISE D'EMBALLAGES ET DE CONDITIONNEMENT - COFREC Société anonyme Emballage pour ampoules pharmaceutiques ou similaires
FR2734795A1 (fr) * 1995-05-31 1996-12-06 Packart Boite en carton, paquet la comprenant, procede et realisation du paquet et son installation, pour objets allonges
EP2050680A1 (fr) * 2007-10-16 2009-04-22 Dividella AG Emballage

Also Published As

Publication number Publication date
EP4037982B1 (fr) 2024-04-10
EP4037982A1 (fr) 2022-08-10

Similar Documents

Publication Publication Date Title
US5441150A (en) Memory module container
US3215332A (en) Carton
US4592480A (en) Tamper evidencing container caps
US3659706A (en) Pharmacal package construction
US2005924A (en) Dispensing carton
EP1893103B1 (fr) Emballage moule
US6135289A (en) Shipping containing and display case for fastening packages
EP2569221B1 (fr) Emballage pour produits pharmaceutiques, en particulier pour des produits parentéraux
CA2546012C (fr) Recipient verrouillable a plateau interne integral
US3961708A (en) Returnable bottle packing case
US3306437A (en) Coded shipping and dispensing carton assembly
WO2014004493A2 (fr) Contenant de distribution, ensemble de produits conditionnés et procédé s'y rapportant
EP2630048B1 (fr) Boîte à l'épreuve des enfants pour des objets et découpe
PT840699E (pt) Recipiente distribuidor com valvula de corredica e selo de origem
US3298504A (en) Display carton
EP4037982B1 (fr) Contenant de produit pharmaceutique
US3057524A (en) Container structure
US4630873A (en) Apparatus for low temperature storage of biological or pharmaceutical samples
EP0908396B1 (fr) Emballage avec etiquette de fermeture
EP0692955B1 (fr) Recipient pour produit a usage medical
US5320215A (en) Vial dispensing carton
EP4093677A1 (fr) Récipient pour produit pharmaceutique
US4934589A (en) Compartmental packaging system with separate access
US3584768A (en) Shipper dispenser package
US12012259B2 (en) Child-resistant package

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20796645

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2020796645

Country of ref document: EP

Effective date: 20220503